PME October 2025 Cover

Navigating the ‘Patient Metro’

Novartis and Matchpoint Therapeutics agree on deal worth $1bn • GSK expands pipeline through $12bn deal with Hengrui • BMS acquires Orbital Therapeutics in $1.5bn deal • Pfizer’s Lorviqua recommended by NICE for lung cancer • Lilly’s early Alzheimer’s disease treatment gets EU approval • Roche’s small cell lung cancer therapy approved by FDA

Lilly and WHO Foundation partner to support global dementia action plan • MHRA marks 100 years of patient safety through biological standards

Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial • La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars

Creativity cages - The surprising way to think out of the box

Resilience – the importance of maintaining our well-being. Resilience isn’t always about standing strong – so how do we grow our own resilience?

In the world of pharma, celebrating the thrill of a new product launch comes naturally. What’s harder, and often overlooked, is managing the portfolio that quietly sustains the business long after the fanfare fades.

The hidden strength of teams: how collaboration can build resilience

The three non-negotiable pillars of Alzheimer’s blood testing. Why sensitivity, access and education will define scalable Alzheimer’s diagnostics

Physician-driven, AI-supported: addressing the clinical trial access gap. To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated referral systems that fit into their clinical workflows

A new advent of clinical pathway management. Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials

A quest for the crown: ruling digital relevance in the age of LLMs. It’s not just about driving clicks and search engine rankings – it’s about shaping the conversation itself.

From disruption to resilience: India’s growing role in pharma logistics. In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever

Communique Awards Advert

Aspire Pharma – enhancing the patient experience through stakeholder engagement. ‘Equipping HCPs with the right tools, resources and knowledge is essential in removing barriers to care’

Navigating the ‘Patient Metro’ – a journey full of insights. The key to unravelling its potential is to focus on the intersections where journeys are made or broken

PRECISION AQ - From insight to impact: strengthening stakeholder engagement across the patient journey

GenAI tools – creating a new era of scientific research. The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed

Excellence in Healthcare Partnerships Awards 2026

New mental health support campaign, Minds on Matters, launched • SAY Communications selects Overcoming MS for its pro bono programme

PME October 2025 Appointments

PME October 2025 Appointments

PME October 2025 - Appointments

PMPS Magazine

CPHI